BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 17851782)

  • 1. [Prognostic significance of metastatic lymph nodes ratio in patients with T2-T3 stage gastric cancer].
    Feng RH; Zhu ZG; Yan M; Chen J; Xiang M; Yin HR; Lin YZ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2007 Sep; 10(5):431-5. PubMed ID: 17851782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The value of metastatic lymph nodes ratio in predicting the prognosis of patients with T3 gastric carcinoma].
    Yu JX; Wu YL; Yang LT
    Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(13):922-5. PubMed ID: 16029534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metastatic lymph node ratio is an independent prognostic factor in gastric cancer.
    Asoglu O; Karanlik H; Parlak M; Kecer M; Muslumanoglu M; Igci A; Ozmen V; Gulluoglu M; Kapran Y
    Hepatogastroenterology; 2009; 56(91-92):908-13. PubMed ID: 19621727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of the ratio between metastatic and dissected lymph nodes (n ratio) in patients with advanced gastric cancer.
    Saito H; Fukumoto Y; Osaki T; Yamada Y; Fukuda K; Tatebe S; Tsujitani S; Ikeguchi M
    J Surg Oncol; 2008 Feb; 97(2):132-5. PubMed ID: 17979134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of metastatic lymph node ratio in T3 gastric cancer.
    Hyung WJ; Noh SH; Yoo CH; Huh JH; Shin DW; Lah KH; Lee JH; Choi SH; Min JS
    World J Surg; 2002 Mar; 26(3):323-9. PubMed ID: 11865369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphadenectomy in gastric cancer: influence on prognosis of lymph node count.
    Giuliani A; Caporale A; Corona M; Di Bari M; Demoro M; Ricciardulli T; Gozzo P; Galati G; Tocchi A
    J Exp Clin Cancer Res; 2004 Jun; 23(2):215-24. PubMed ID: 15354405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positive lymph node ratio is an independent prognostic factor in gastric cancer after d2 resection regardless of the examined number of lymph nodes.
    Xu DZ; Geng QR; Long ZJ; Zhan YQ; Li W; Zhou ZW; Chen YB; Sun XW; Chen G; Liu Q
    Ann Surg Oncol; 2009 Feb; 16(2):319-26. PubMed ID: 19050970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of level and number of lymph node metastases in patients with gastric cancer.
    Saito H; Fukumoto Y; Osaki T; Fukuda K; Tatebe S; Tsujitani S; Ikeguchi M
    Ann Surg Oncol; 2007 May; 14(5):1688-93. PubMed ID: 17245613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prognostic value of metastatic lymph node ratio for gastric cancer patients with less than 15 lymph nodes dissection].
    Liu HG; Liang H; Deng JY; Wang L; Liang YX; Jiao XG
    Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Feb; 16(2):151-4. PubMed ID: 23446476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes.
    Alatengbaolide ; Lin D; Li Y; Xu H; Chen J; Wang B; Liu C; Lu P
    Am J Clin Oncol; 2013 Aug; 36(4):325-30. PubMed ID: 22547011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is metastatic lymph node ratio superior to the number of metastatic lymph nodes to assess outcome and survival of gastric cancer?
    Bilici A; Ustaalioglu BB; Gumus M; Seker M; Yilmaz B; Kefeli U; Yildirim E; Sonmez B; Salepci T; Kement M; Mayadagli A
    Onkologie; 2010; 33(3):101-5. PubMed ID: 20215800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastatic lymph node ratio versus number of metastatic lymph nodes as a prognostic factor in gastric cancer.
    Espín F; Bianchi A; Llorca S; Feliu J; Palomera E; García O; Remon J; Suñol X
    Eur J Surg Oncol; 2012 Jun; 38(6):497-502. PubMed ID: 22445061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relationship between metastatic rate and amount of lymph nodes and prognosis of gastric cancer].
    Li K; Xu HM; Chen JQ
    Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(30):2113-6. PubMed ID: 16313820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ratio of metastatic to resected lymph nodes for prediction of survival in patients with inadequately staged gastric cancer.
    Kulig J; Sierzega M; Kolodziejczyk P; Popiela T;
    Br J Surg; 2009 Aug; 96(8):910-8. PubMed ID: 19591164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the prognostic significance between the number of metastatic lymph nodes and nodal stage in gastric carcinoma.
    Kato M; Saji S; Kawaguchi Y; Kunieda K; Sugiyama Y; Takagi Y; Hiraoka T; Kumazawa I; Adachi T
    Hepatogastroenterology; 1999; 46(30):3281-6. PubMed ID: 10626202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracapsular lymph node spread: a new prognostic factor in gastric cancer.
    Alakus H; Hölscher AH; Grass G; Hartmann E; Schulte C; Drebber U; Baldus SE; Bollschweiler E; Metzger R; Mönig SP
    Cancer; 2010 Jan; 116(2):309-15. PubMed ID: 19950124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Log odds of positive lymph nodes: a novel prognostic indicator superior to the number-based and the ratio-based N category for gastric cancer patients with R0 resection.
    Sun Z; Xu Y; Li de M; Wang ZN; Zhu GL; Huang BJ; Li K; Xu HM
    Cancer; 2010 Jun; 116(11):2571-80. PubMed ID: 20336791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical impact of metastatic lymph node ratio in advanced gastric cancer.
    Kunisaki C; Shimada H; Nomura M; Matsuda G; Otsuka Y; Ono H; Akiyama H
    Anticancer Res; 2005; 25(2B):1369-75. PubMed ID: 15865093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Metastasis rates of lymph nodes and distribution in advanced gastric cancer and its clinical significance].
    Nzengue JC; Zhan WH; Wang JP; Dong WG; Lan P; He YL; Chen ZX; Cai SR
    Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Nov; 9(6):506-9. PubMed ID: 17143796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic value of N-ratio in patients with gastric cancer: validation in a large, multicenter series.
    Marchet A; Mocellin S; Ambrosi A; de Manzoni G; Di Leo A; Marrelli D; Roviello F; Morgagni P; Saragoni L; Natalini G; De Santis F; Baiocchi L; Coniglio A; Nitti D;
    Eur J Surg Oncol; 2008 Feb; 34(2):159-65. PubMed ID: 17566691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.